Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (311-320 of 546) with videos related to

Pageof 55
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 21, 2005
The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophreniaGerhard Gründer, Christian Landvogt, Ingo Vernaleken, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2021
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibitionMarcus Unterrainer, Julian Taugner, Lukas Käsmann, et al.
Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) <sup>18</sup>F-RadiopharmaceuticalsLexi Gower-Fry, Travis Kronemann, Andreas Dorian, et al.
International Journal of Molecular Sciences|June 28, 2023
Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S MiceLea Helena Kunze, François Ruch, Gloria Biechele, et al.
International Journal of Cancer|October 1, 2015
Anticalins directed against the fibronectin extra domain B as diagnostic tracers for glioblastomasValerie Albrecht, Antonia Richter, Sarah Pfeiffer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2005
Parametric mapping of binding in human brain of D2 receptor ligands of different affinitiesThomas Siessmeier, Yun Zhou, Hans-Georg Buchholz, et al.
Clinical Nuclear Medicine|October 16, 2020
Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PETFranziska J Vettermann, Marcus Unterrainer, Viktoria Ruf, et al.
Epilepsia|July 17, 2010
Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsyHero Bartmann, Christina Fuest, Christian la Fougere, et al.
Bioconjugate Chemistry|November 19, 2010
One-step ¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET)Carmen Wängler, Beatrice Waser, Andrea Alke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 4, 2012
Left ventricular dyssynchrony assessed by gated SPECT phase analysis is an independent predictor of death in patients with advanced coronary artery disease and reduced left ventricular function not undergoing cardiac resynchronization therapyChristopher Uebleis, Stefan Hellweger, Rüdiger Paul Laubender, et al.
Pageof 55

Showing results (311-320 of 546) with videos related to

Sort By:
Pageof 55
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 21, 2005
The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophreniaGerhard Gründer, Christian Landvogt, Ingo Vernaleken, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2021
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibitionMarcus Unterrainer, Julian Taugner, Lukas Käsmann, et al.
Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) <sup>18</sup>F-RadiopharmaceuticalsLexi Gower-Fry, Travis Kronemann, Andreas Dorian, et al.
International Journal of Molecular Sciences|June 28, 2023
Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S MiceLea Helena Kunze, François Ruch, Gloria Biechele, et al.
International Journal of Cancer|October 1, 2015
Anticalins directed against the fibronectin extra domain B as diagnostic tracers for glioblastomasValerie Albrecht, Antonia Richter, Sarah Pfeiffer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2005
Parametric mapping of binding in human brain of D2 receptor ligands of different affinitiesThomas Siessmeier, Yun Zhou, Hans-Georg Buchholz, et al.
Clinical Nuclear Medicine|October 16, 2020
Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PETFranziska J Vettermann, Marcus Unterrainer, Viktoria Ruf, et al.
Epilepsia|July 17, 2010
Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsyHero Bartmann, Christina Fuest, Christian la Fougere, et al.
Bioconjugate Chemistry|November 19, 2010
One-step ¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET)Carmen Wängler, Beatrice Waser, Andrea Alke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 4, 2012
Left ventricular dyssynchrony assessed by gated SPECT phase analysis is an independent predictor of death in patients with advanced coronary artery disease and reduced left ventricular function not undergoing cardiac resynchronization therapyChristopher Uebleis, Stefan Hellweger, Rüdiger Paul Laubender, et al.
Pageof 55